T cell abnormalities in systemic sclerosis with a focus on Th17 cells.

Area of Science:

• Immunology
• Rheumatology
• Connective Tissue Diseases

Background:

• Systemic sclerosis (SSc) is an autoimmune connective tissue disorder marked by vascular issues and fibroblast activation, leading to organ fibrosis.
• The immune system, particularly T cells and autoantibodies, plays a crucial role in SSc pathogenesis.
• Early disease stages show oligoclonal T cells producing type 2 cytokines, promoting fibrosis.

Purpose of the Study:

• To review recent findings on T helper cell subsets in SSc.
• To discuss the potential role of Th17 cells in SSc.
• To highlight the significance of immune abnormalities for novel therapy development.

Main Methods:

• Review of recent scientific literature and data.
• Analysis of T cell subsets and cytokine expression in SSc patients.
• Discussion of immunological mechanisms in SSc.

Main Results:

• Increased presence of various T helper cells, including Th17 cells, observed in SSc patients.
• Th17 cells and their cytokines are found in peripheral blood, serum, and skin of individuals with SSc.
• Oligoclonal T cells producing type 2 cytokines contribute to fibrosis by stimulating fibroblasts.

Conclusions:

• T helper cell abnormalities are characteristic of Systemic Sclerosis.
• Th17 cells may play a dual role, promoting inflammation while potentially limiting fibrosis.
• Further understanding of SSc immunology is crucial for identifying effective therapeutic strategies.